HENDERSON MOLLY (CFO and CBO) sold 3.9% of their position (3.68K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $16.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/8/2025ACC: 0000950170-25-052156
Officer· CFO and CBO
Since Apr 2022
-3.68K
Net shares
Net seller
$16.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.68K
Price / share
$4.55
Trade value
$16.74K
% of position
3.9%
4/7/2025
93.55K→89.87K
Total
Net shares
−3.68K
Net value
-$16.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2025 | S · Sale | −3.68K | $4.55 | $16.74K | 3.9% | 93.55K | 89.87K |
| Total | −3.68K | -$16.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported